| HGNC Family | Non-coding RNAs |
| Name | highly accelerated region 1A (non-protein coding) |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n HAR1A is a long non‐coding RNA encoded within a human accelerated region that has undergone rapid evolution and is distinctly expressed in the developing human neocortex—specifically in Cajal–Retzius neurons—suggesting a role in cortical neuron specification and in shaping the features of human cognition."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In addition to this neurodevelopmental function, multiple independent studies have revealed that reduced HAR1A expression is associated with tumor progression in several malignancies. In breast and papillary thyroid cancers, for instance, HAR1A is part of larger prognostic signatures whose deregulation correlates with tumor recurrence and poor patient survival."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Similarly, in gliomas, lowered HAR1A levels are linked to higher proliferation markers and more aggressive tumor behavior"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", while in hepatocellular carcinoma decreased expression of HAR1A serves as an independent predictor of shorter overall survival."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Mechanistic insights from oral cancer further indicate that HAR1A functions as a tumor suppressor by modulating key signaling pathways—its knockdown leading to increased ALPK1 expression, decreased BRD7 levels, and the promotion of inflammation and epithelial–mesenchymal transition."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Collectively, these findings underscore the multifaceted roles of HAR1A in both establishing critical aspects of human brain development and in acting as a suppressor of tumor progression across a variety of cancer types.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Katherine S Pollard, Sofie R Salama, Nelle Lambert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An RNA gene expressed during cortical development evolved rapidly in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature05113"}], "href": "https://doi.org/10.1038/nature05113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16915236"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16915236"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Melanie Ziegeler, Mirko Cevec, Christian Richter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NMR studies of HAR1 RNA secondary structures reveal conformational dynamics in the human RNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Chembiochem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbic.201200401"}], "href": "https://doi.org/10.1002/cbic.201200401"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22961937"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22961937"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Hairong Liu, Juan Li, Pratirodh Koirala, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNAs as prognostic markers in human breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.7828"}], "href": "https://doi.org/10.18632/oncotarget.7828"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26942882"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26942882"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Ben Ma, Tian Liao, Duo Wen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep36973"}], "href": "https://doi.org/10.1038/srep36973"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27833134"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27833134"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Hecun Zou, Lan-Xiang Wu, Yonglong Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.20226"}], "href": "https://doi.org/10.18632/oncotarget.20226"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29108264"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29108264"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Chuming Tao, Haitao Luo, Luyue Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1951927"}], "href": "https://doi.org/10.1080/21655979.2021.1951927"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34288803"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34288803"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Zhenjing Shi, Ya Luo, Minghui Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression Analysis of Long Non-Coding RNA HAR1A and HAR1B in HBV-Induced Hepatocullular Carcinoma in Chinese Patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lab Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/labmed/lmy055"}], "href": "https://doi.org/10.1093/labmed/lmy055"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30304523"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30304523"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Chi-Pin Lee, Albert Min-Shan Ko, Srinivasan Nithiyanantham, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA HAR1A regulates oral cancer progression through the alpha-kinase 1, bromodomain 7, and myosin IIA axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Med (Berl) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00109-021-02095-x"}], "href": "https://doi.org/10.1007/s00109-021-02095-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34097087"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34097087"}]}]}]}
|
| Synonyms | LINC00064, HAR1F, NCRNA00064 |
| NCBI Gene ID | 768096 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
HAR1A has 1,528 functional associations with biological entities spanning 6 categories (molecular profile, functional term, phrase or reference, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 24 datasets.
Click the + buttons to view associations for HAR1A from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of HAR1A gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of HAR1A gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of HAR1A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of HAR1A gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of HAR1A gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of HAR1A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of HAR1A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at HAR1A gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of HAR1A gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of HAR1A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with HAR1A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of HAR1A gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of HAR1A gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of HAR1A gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of HAR1A gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of HAR1A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of HAR1A gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of HAR1A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of HAR1A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of HAR1A gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of HAR1A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of HAR1A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at HAR1A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of HAR1A gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |